Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

Pietro Lampertico^*, Stefan Mauss, Marcello Persico, Stephen T. Barclay, Steven Marx, Kristina Lohmann, Mark Bondin, Zhen Zhen Zhang, Fiona Marra, Pamela S. Belperio, Heiner Wedemeyer, Steven Flamm

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

1 results
- Title
- Start date(ascending)

Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis
Lampertico, P. (Creator), Mauss, S. (Creator), Persico, M. (Creator), Barclay, S. T. (Creator), Marx, S. (Creator), Lohmann, K. (Creator), Bondin, M. (Creator), Zhang, Z. (Creator), Marra, F. (Creator), Belperio, P. S. (Creator), Wedemeyer, H. (Creator), Flamm, S. (Creator) & Mauss, S. (Creator), Adis Journals, 2020
DOI: 10.6084/m9.figshare.12652802.v1, https://adisjournals.figshare.com/articles/Real-World_Clinical_Practice_Use_of_8-Week_Glecaprevir_Pibrentasvir_in_Treatment-Na_ve_Patients_with_Compensated_Cirrhosis/12652802/1
Dataset

Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

Datasets

Search results

Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis